This inventor holds 1 USPTO granted patent. Top assignee: Hk Inno.n Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mi Jeong Son: Innovator in Pharmaceutical Composition
Introduction
Mi Jeong Son is a prominent inventor based in Busan, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating colitis. Her innovative work has garnered attention in the scientific community.
Latest Patents
Mi Jeong Son holds a patent for a pharmaceutical composition comprising a benzimidazole derivative compound. The patent details a composition for preventing or treating colitis, which includes tegoprazan as an effective ingredient. This invention represents a notable advancement in therapeutic options for patients suffering from this condition.
Career Highlights
Mi Jeong Son is associated with Hk Inno.n Corporation, where she continues to push the boundaries of pharmaceutical research. Her dedication to innovation has led to the development of effective treatments that can improve patient outcomes.
Collaborations
Some of her notable coworkers include Seung Won Kim and Dongkyu Kim. Their collaborative efforts contribute to the success of their projects and the advancement of their research initiatives.
Conclusion
Mi Jeong Son's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions are paving the way for new treatments that can significantly benefit patients.